Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study-Reference-Cited by-全球学者库

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Published:2021-07 Issue:10297 Volume:398 Page:314-324
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Berdeja Jesus G,Madduri Deepu,Usmani Saad Z,Jakubowiak Andrzej,Agha Mounzer,Cohen Adam D,Stewart A Keith,Hari Parameswaran,Htut Myo,Lesokhin Alexander,Deol Abhinav,Munshi Nikhil C,O'Donnell Elizabeth,Avigan David,Singh Indrajeet,Zudaire Enrique,Yeh Tzu-Min,Allred Alicia J,Olyslager Yunsi,Banerjee Arnob,Jackson Carolyn C,Goldberg Jenna D,Schecter Jordan M,Deraedt William,Zhuang Sen Hong,Infante Jeffrey,Geng Dong,Wu Xiaoling,Carrasco-Alfonso Marlene J,Akram Muhammad,Hossain Farah,Rizvi Syed,Fan Frank,Lin Yi,Martin Thomas,Jagannath Sundar

Funder

Janssen Research and Development LLC

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Treatment journeys of patients with newly diagnosed multiple myeloma (NDMM): results from the Connect MM registry;Jagannath;Clin Lymphoma Myeloma Leuk,2020

2. Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy;Gandhi;Leukemia,2019

3. oral selinexor-dexamethasone for triple-class refractory multiple myeloma;Chari;N Engl J Med,2019

4. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study;Lonial;Lancet Oncol,2020

5. A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma;Zhao;J Hematol Oncol,2018

Cited by 649 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Miniaturized CAR knocked onto CD3ε extends TCR function with CAR specificity under control of endogenous TCR signaling cascade;Journal of Immunological Methods;2024-03

2. Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer;Journal of Controlled Release;2024-03

3. Irradiated Microparticles Suppress Prostate Cancer by Tumor Microenvironment Reprogramming and Ferroptosis;2024-02-06

4. Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition;Cell Death & Disease;2024-02-02

5. GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review;Blood Cancer Journal;2024-02-02